Usefulness of preoperative FDG-PET for detection of gastric cancer

HW Yeung, 1998, Clin Positron Imaging, 1, 213, 10.1016/S1095-0397(98)00018-1

A Stahl, 2003, Eur J Nucl Med, 30, 288, 10.1007/s00259-002-1029-5

E Mochiki, 2004, World J Surg, 28, 247, 10.1007/s00268-003-7191-5

J Chen, 2005, Cancer, 103, 2383, 10.1002/cncr.21074

H Koga, 2003, Ann Nucl Med, 17, 733, 10.1007/BF02984984

Japanese Gastric Cancer Association, 1998, Gastric Cancer, 1, 10, 10.1007/PL00011681

SR Hamilton, 2000, WHO classification of tumors. Pathology and genetics, tumors of the digestive system, 38

MP Stokkel, 2000, Ann Surg, 231, 229, 10.1097/00000658-200002000-00012

Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koëter GH, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;254–61

P Flamen, 2002, Best Pract Res Clin Gastroenterol, 16, 237, 10.1053/bega.2001.0283

P Flamen, 2000, J Clin Oncol, 18, 3202, 10.1200/JCO.2000.18.18.3202

T Kawamura, 2001, Cancer, 92, 634, 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X

H Ohira, 2000, J Nucl Med, 41, 1561

Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T, et al. Tracer feasibility of monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, l-[methyl-14C]methionine, [6-3H] thymidine, and gallium-67. J Nucl Med 1991;2118–23